Company / Current Assets per Share
MADRIGAL PHARMACEUTICALS, INC. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$56.61
FY2025
5-year range
$17.52 / $56.61
FY2021-FY2025
Trend
+8.9%
vs FY2024
Sector context
#10 of 210
Health Care
What the data says
Among 210 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the top 5% for current assets per share. Current Assets per Share has increased for 4 consecutive years, from $17.52 in FY2021 to $56.61 in FY2025.
Based on SEC 10-K filings.
56.61 in FY2025 with a 5-year CAGR of +25.1%. Top quartile in the Health Care sector.
Improved from $35.20 to $56.61 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +39.0%
- 5-Year CAGR
- +25.1%
- 10-Year CAGR
- -
Sector benchmark
-66.8% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s current assets per share has grown for 4 consecutive years.
- In FY2025, current assets per share increased 8.9% year-over-year.
- Ranks #10 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.61 | +8.9% |
| FY2024 | $51.97 | +47.6% |
| FY2023 | $35.20 | +66.9% |
| FY2022 | $21.09 | +20.4% |
| FY2021 | $17.52 | -5.2% |
| FY2020 | $18.48 | -35.4% |
| FY2019 | $28.59 | -12.8% |
| FY2018 | $32.79 | +109.1% |
| FY2017 | $15.68 | +98.1% |
| FY2016 | $7.92 | +579.3% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026